▁London 8.330493927001953
- 3.5330348014831543
based 0.3282795548439026
▁ph 8.07450008392334
arma 0.20494826138019562
ce 0.2553548514842987
ut 0.0016818471485748887
ical 0.0005779744242317975
▁company 0.9030613899230957
▁Sky 8.268077850341797
e 0.41552841663360596
Ph 2.0567924976348877
arma 0.009668448008596897
▁has 1.2923673391342163
▁predicted 10.041494369506836
▁that 1.056841492652893
▁ 3.7987961769104004
1 2.601112127304077
9 2.1718974113464355
9 0.13941025733947754
8 1.4194952249526978
▁will 0.5790928602218628
▁be 0.23191750049591064
▁a 0.7008230686187744
▁“ 2.702132225036621
mag 8.632753372192383
ic 0.5621620416641235
▁year 0.29198724031448364
” 0.17230653762817383
▁of 5.441547393798828
▁growth 1.8406718969345093
▁for 0.9930882453918457
▁its 1.2521792650222778
▁invest 7.7071332931518555
ors 0.16148623824119568
▁and 3.16220760345459
▁share 1.75881028175354
hold 0.08360694348812103
ers 0.0004781435418408364
, 1.531260371208191
▁thanks 2.6435658931732178
▁to 0.13672694563865662
▁a 1.8632640838623047
▁number 2.257352113723755
▁of 0.002855380065739155
▁up 3.8213863372802734
coming 0.0713798776268959
▁product 1.7057396173477173
▁launch 0.13021090626716614
es 0.003230838105082512
▁and 1.4713815450668335
▁partners 4.316876411437988
hips 0.32153281569480896
. 0.4016926884651184
<0x0A> 0.5458249449729919
S 1.741396427154541
ky 0.026636188849806786
e 0.004924661945551634
Ph 0.1894426941871643
arma 0.002795606851577759
▁has 1.9740252494812012
▁a 2.4859366416931152
▁strong 3.131181478500366
▁track 3.046264171600342
▁record 0.044157736003398895
▁of 0.6413863897323608
▁developing 1.987610101699829
▁and 1.929571270942688
▁commercial 1.9612363576889038
izing 1.6841959953308105
▁innov 2.5263118743896484
ative 0.01013251207768917
▁drug 1.925793170928955
▁delivery 0.4649876058101654
▁techn 1.01166832447052
ologies 0.0007227290188893676
, 1.2419883012771606
▁including 2.3376498222351074
▁in 2.550008773803711
hal 0.14478233456611633
ation 0.7869480848312378
▁and 1.5471453666687012
▁or 1.8342653512954712
al 0.022919602692127228
▁form 2.6909029483795166
ulations 0.057316169142723083
. 0.3652091324329376
▁Its 2.5404129028320312
▁current 2.672819137573242
▁product 1.5169830322265625
▁port 0.5486431121826172
folio 0.00028155234758742154
▁includes 0.10902784764766693
▁treat 4.838464736938477
ments 0.0001162358166766353
▁for 0.004009525757282972
▁resp 1.4535014629364014
ir 0.00022753680241294205
atory 4.95922940899618e-05
▁dise 1.1999895572662354
ases 3.862455560010858e-05
, 0.29657793045043945
▁pain 1.6778335571289062
▁management 0.7936061024665833
, 0.1002672091126442
▁and 0.16532862186431885
▁mig 4.18994140625
raine 0.14133495092391968
▁relief 4.168461799621582
. 0.25048622488975525
<0x0A> 0.12760590016841888
The 1.4123355150222778
▁company 0.02772289328277111
▁has 1.5090919733047485
▁several 2.4295971393585205
▁major 2.7540481090545654
▁product 0.8697954416275024
▁launch 0.009761917404830456
es 0.0003258521028328687
▁scheduled 1.3191354274749756
▁for 0.008562641218304634
▁ 0.2117415815591812
1 0.05341164395213127
9 8.344998059328645e-05
9 8.631125092506409e-05
8 0.006321701221168041
, 0.08523773401975632
▁including 0.07131253927946091
▁a 1.361914038658142
▁new 0.44220277667045593
▁in 0.4526602029800415
hal 0.09537380933761597
er 1.630454659461975
▁for 0.29191938042640686
▁the 0.5836136937141418
▁treatment 0.02860369347035885
▁of 0.00019105113460682333
▁chron 1.6328580379486084
ic 1.7047073924914002e-05
▁ob 0.06599742919206619
struct 0.0008264021598733962
ive 0.00012863508891314268
▁pul 0.0023424620740115643
mon 4.3750766053562984e-05
ary 6.6757424974639434e-06
▁disease 0.008724549785256386
▁( 0.049011483788490295
CO 0.0011669646482914686
PD 1.8596821973915212e-05
), 0.826213002204895
▁which 1.0952850580215454
▁affect 5.233487129211426
s 0.00020118591783102602
▁millions 0.6934208869934082
▁of 0.013867120258510113
▁people 0.019519172608852386
▁world 0.10934656113386154
wide 7.260109123308212e-05
. 0.03148428723216057
▁Sky 1.0901033878326416
e 0.00025376916164532304
Ph 0.004420020617544651
arma 0.0006763837882317603
’ 1.3309693336486816
s 1.3709161976294126e-05
▁new 3.116926670074463
▁in 0.13691428303718567
hal 0.0007645429577678442
er 0.013085553422570229
▁uses 3.175837993621826
▁a 0.3990558683872223
▁unique 0.6672453284263611
▁dry 3.8294761180877686
▁pow 0.25652629137039185
der 6.640177889494225e-05
▁form 0.5100412964820862
ulation 0.0020447401329874992
▁that 0.3056581914424896
▁is 0.7287609577178955
▁easier 0.9597326517105103
▁to 0.11178319156169891
▁use 0.044735945761203766
▁and 0.8998802304267883
▁more 0.19600065052509308
▁convenient 1.9350026845932007
▁for 0.7225528359413147
▁patients 0.0029800788033753633
▁than 0.3018937110900879
▁traditional 0.36854058504104614
▁in 0.4563317894935608
hal 0.004070209339261055
ers 0.06258019804954529
. 0.05167729780077934
<0x0A> 0.3445509374141693
In 0.4663781523704529
▁addition 0.008294675499200821
, 1.644808053970337
▁Sky 0.310259610414505
e 9.823327854974195e-05
Ph 0.0008715015137568116
arma 0.0008529484621249139
▁is 0.6837001442909241
▁entering 6.587735176086426
▁into 0.09868431091308594
▁several 0.9251047968864441
▁partners 0.8334953188896179
hips 0.020620130002498627
▁and 4.253282070159912
▁lic 1.6381257772445679
ens 0.011794590391218662
ing 8.690734830452129e-05
▁agre 0.1857452094554901
ements 9.536747711536009e-07
▁that 0.9959783554077148
▁will 0.3797827959060669
▁expand 2.1775810718536377
▁its 0.18308025598526
▁product 0.18925169110298157
▁offer 3.470655679702759
ings 1.406679530191468e-05
▁and 0.16105103492736816
▁market 4.064246654510498
▁reach 0.043583162128925323
. 0.010777104645967484
▁The 0.8489822149276733
▁company 0.0052653043530881405
▁recently 1.6320252418518066
▁signed 1.1615313291549683
▁a 0.1681908220052719
▁deal 0.9261612892150879
▁with 0.004998818971216679
▁US 4.780817985534668
- 0.1727137267589569
based 0.0003531602560542524
▁drug 1.4122347831726074
maker 0.7982513904571533
▁El 5.603461742401123
an 0.01548729557543993
▁Ph 1.4758117198944092
arma 7.37932714400813e-05
ce 0.017566470429301262
ut 3.9220627513714135e-05
ical 3.230623769923113e-05
s 0.003917669411748648
▁to 0.08804289996623993
▁develop 0.20113471150398254
▁novel 7.161909580230713
▁drug 2.3390610218048096
▁delivery 0.17580321431159973
▁techn 0.6226504445075989
ologies 1.120573597290786e-05
▁for 0.07893449068069458
▁the 1.0417060852050781
▁treatment 0.02588697150349617
▁of 0.0002307561953784898
▁ne 1.7512761354446411
uro 0.11501506716012955
log 0.23602627217769623
ical 0.0002889454481191933
▁dis 0.513782262802124
orders 1.3709161976294126e-05
. 0.38554054498672485
▁It 7.089633941650391
▁also 1.042514443397522
▁announced 2.1505541801452637
▁a 0.24889354407787323
▁lic 2.6860156059265137
ens 0.0006312335608527064
ing 5.722209607483819e-05
▁agreement 0.021884283050894737
▁with 0.00339039065875113
▁Italy 6.3526692390441895
’ 0.8844370245933533
s 2.324608067283407e-05
▁Ch 1.3417906761169434
ies 0.03300735354423523
i 0.0005355719476938248
▁Far 0.18230657279491425
ma 2.694166323635727e-05
ce 0.0003383732109796256
ut 0.002285945462062955
ici 0.022882219403982162
▁for 1.2943124771118164
▁the 0.3875972032546997
▁distribution 4.458755970001221
▁and 2.887624502182007
▁market 0.9907218217849731
ing 0.0004012793651781976
▁of 0.0089570889249444
▁a 2.562267303466797
▁range 4.709139347076416
▁of 0.00013221184781286865
▁resp 1.2996108531951904
ir 0.00045786850387230515
atory 1.811997572076507e-05
▁products 0.7160869836807251
▁in 0.17272263765335083
▁Europe 0.4379200339317322
. 0.15119117498397827
<0x0A> 0.012471215799450874
“ 2.59484601020813
We 0.4567914605140686
’ 3.1489017009735107
re 0.10930226743221283
▁very 0.8165891766548157
▁optim 2.281675100326538
istic 7.629423635080457e-06
▁about 0.0018241343786939979
▁our 2.0755701065063477
▁prospect 0.6284184455871582
s 4.22009798057843e-05
▁for 0.08931870013475418
▁ 0.20428630709648132
1 0.0010913603473454714
9 2.5034263671841472e-05
9 2.253080856462475e-05
8 0.00042453475180082023
▁and 1.233664631843567
▁beyond 0.027405941858887672
,” 0.04646839201450348
▁said 0.05426225811243057
▁Sky 0.30631351470947266
e 0.00025985040701925755
Ph 0.0012467524502426386
arma 9.310679160989821e-05
▁CE 0.28303056955337524
O 3.0756469641346484e-05
▁Jer 5.096036911010742
emy 0.1316778063774109
▁Sc 9.605433464050293
ud 1.8752548694610596
am 1.2912918329238892
ore 0.00013912690337747335
. 0.26968979835510254
▁“ 0.003308278974145651
We 0.8646722435951233
▁have 0.27023571729660034
▁a 0.11736669391393661
▁number 3.995614528656006
▁of 0.00010264446609653533
▁exc 0.6713359355926514
iting 1.7881409348774469e-06
▁new 1.4097192287445068
▁products 0.06799832731485367
▁in 0.27680253982543945
▁development 0.7613145112991333
, 0.5350542068481445
▁as 2.3363940715789795
▁well 9.894419235934038e-06
▁as 0.0001749549264786765
▁strong 2.8302783966064453
▁partners 0.06400556117296219
hips 0.0020368562545627356
▁in 2.3799517154693604
▁place 0.0006879550055600703
▁that 0.18451322615146637
▁will 0.047927673906087875
▁help 0.294534832239151
▁us 0.048722196370363235
▁achieve 3.360710620880127
▁our 0.03100086748600006
▁growth 0.9530680179595947
▁targets 2.093575954437256
.” 0.6262140274047852
<0x0A> 0.04980336129665375
In 3.5224831104278564
vest 0.33820679783821106
ors 0.031614210456609726
▁seem 5.162168979644775
▁b 5.2504563331604
ull 7.37932714400813e-05
ish 2.7537724236026406e-05
▁on 0.2349640280008316
▁Sky 0.1552879959344864
e 0.0005599039723165333
Ph 0.00384125835262239
arma 0.00011981251736870036
’ 0.18985579907894135
s 6.008328637108207e-05
▁prospect 0.4974381923675537
s 0.00011349369015078992
▁as 2.463254690170288
▁well 0.04658878594636917
▁– 4.043618679046631
▁the 0.1982438713312149
▁company 0.020422885194420815
’ 0.03544618561863899
s 0.00010300213034497574
▁stock 0.9238582253456116
▁price 0.6796858906745911
▁has 0.025557272136211395
▁ris 1.1535805463790894
en 1.3113029808664578e-06
▁stead 1.6989784240722656
ily 1.609338323760312e-05
▁over 0.4476822018623352
▁the 0.003554215654730797
▁past 0.05053674057126045
▁year 0.2071523666381836
, 0.21078822016716003
▁and 0.4668335020542145
▁anal 0.38412168622016907
yst 8.344653679159819e-07
s 0.0010711324866861105
▁are 0.9573992490768433
▁predict 0.5054040551185608
ing 5.8175828598905355e-05
▁continued 1.3750227689743042
▁growth 0.06915093958377838
▁in 0.18644775450229645
▁ 0.7083839774131775
1 0.029640166088938713
9 7.128969446057454e-05
9 7.725060277152807e-05
8 0.0060660275630652905
. 0.7689527273178101
<0x0A> 1.240364909172058
“ 2.954803466796875
S 0.714480459690094
ky 0.0002774981257971376
e 0.0005783322267234325
Ph 0.004317710641771555
arma 0.0001914088352350518
▁has 2.166539430618286
▁a 0.6236972808837891
▁strong 0.5898621082305908
▁pipeline 1.0670422315597534
▁of 0.011677471920847893
▁innov 1.282997488975525
ative 0.0001586801663506776
▁products 0.3616698384284973
▁and 0.5803520083427429
▁a 0.6045418381690979
▁proven 2.838974714279175
▁track 0.014026626013219357
▁record 0.00025746558094397187
▁of 0.02433653175830841
▁commercial 1.6008102893829346
▁success 0.5318845510482788
,” 0.03788738325238228
▁said 0.017441941425204277
▁ph 5.806079387664795
arma 0.0022294919472187757
ce 0.01611330173909664
ut 7.581998215755448e-05
ical 0.0001040751303662546
s 3.3793954849243164
▁anal 0.3488262891769409
yst 8.940736734075472e-06
▁Caroline 7.227445602416992
▁Davis 5.72711706161499
. 0.3990591764450073
▁“ 0.00405123783275485
There 6.189754009246826
’ 0.2751381993293762
s 5.3049541747896e-05
▁a 0.6250588893890381
▁lot 0.04367537051439285
▁of 0.11481568962335587
▁excitement 1.4370415210723877
▁and 5.303070068359375
▁anticip 2.370361328125
ation 4.20817596022971e-05
▁among 3.030658483505249
▁invest 0.018037674948573112
ors 7.29587409296073e-05
▁about 0.794748842716217
▁what 0.16773061454296112
▁they 4.03453254699707
▁will 3.189668893814087
▁achieve 1.4880794286727905
▁in 0.6276852488517761
▁the 1.4909336566925049
▁coming 0.1731221228837967
▁year 0.5086182951927185
.” 0.020021457225084305
<0x0A> 0.06436128169298172
For 3.5625224113464355
▁its 3.7658309936523438
▁part 0.18148522078990936
, 0.0008550960919819772
▁Sky 0.052270423620939255
e 0.00026020812219940126
Ph 0.0019863289780914783
arma 5.8533474657451734e-05
▁is 0.14003585278987885
▁focused 0.5555742383003235
▁on 0.0014264023629948497
▁continu 1.710395097732544
ing 0.00013411944382824004
▁to 0.05845336988568306
▁develop 0.6349985599517822
▁techn 9.108838081359863
ologies 0.07203342765569687
▁that 0.08945270627737045
▁improve 1.3552533388137817
▁the 1.4011555910110474
▁delivery 1.0054779052734375
▁and 1.1184277534484863
▁effic 0.8914026021957397
acy 8.76226622494869e-05
▁of 0.00029985629953444004
▁medic 0.9076002240180969
ations 0.48946088552474976
▁for 2.8026628494262695
▁a 2.2358129024505615
▁wide 0.5708256363868713
▁range 0.02346844971179962
▁of 0.000626700755674392
▁th 3.992818593978882
era 1.406679530191468e-05
pe 1.4305124977909145e-06
ut 9.059946933120955e-06
ic 0.0004850609984714538
▁areas 0.04364112764596939
. 0.04723544791340828
<0x0A> 2.480896234512329
“ 0.21724772453308105
We 0.3606647551059723
’ 0.5998244285583496
re 0.018015339970588684
▁committed 0.5833223462104797
▁to 4.22009798057843e-05
▁stay 4.610488414764404
ing 0.0012379199033603072
▁on 3.539937734603882
▁the 0.01492726244032383
▁cutting 0.32211416959762573
▁edge 0.01736673340201378
▁of 0.005009841173887253
▁drug 0.13839036226272583
▁delivery 0.06983920931816101
,” 4.553127288818359
▁said 0.1700870245695114
▁Sc 0.09174458682537079
ud 8.178091957233846e-05
am 0.0008744843653403223
ore 3.755163197638467e-05
. 0.00900845043361187
▁“ 0.004558985587209463
O 0.8865684270858765
ur 1.5974172129062936e-05
▁goal 0.21822606027126312
▁is 7.641607226105407e-05
▁to 0.007615222595632076
▁provide 1.2059719562530518
▁patients 0.11976379156112671
▁with 0.06298885494470596
▁better 2.224020481109619
, 1.4571138620376587
▁more 0.37522485852241516
▁effective 0.871837854385376
▁treat 0.16681353747844696
ments 1.5139694369281642e-05
▁that 0.264228880405426
▁improve 0.3459075689315796
▁their 0.013461429625749588
▁quality 0.04355670511722565
▁of 0.00036448921309784055
▁life 0.00010014082363341004
.” 0.02406332641839981
<0x0A> 0.15756556391716003
With 2.1028642654418945
▁a 1.1784007549285889
▁prom 4.564637660980225
ising 9.119926107814535e-05
▁pipeline 0.8963954448699951
▁of 0.11086206138134003
▁products 0.4113827049732208
▁and 0.07709451764822006
▁strong 1.4728232622146606
▁partners 0.12458384037017822
hips 0.0028557388577610254
▁in 0.026165874674916267
▁place 0.000470629776827991
, 0.0017839479260146618
▁Sky 0.5859736204147339
e 0.00028775300597772
Ph 0.0017769020050764084
arma 5.686445001629181e-05
▁seems 3.513474225997925
▁well 0.6809485554695129
- 0.3900265395641327
position 0.0659065768122673
ed 0.0001442536449758336
▁to 0.24650366604328156
▁deliver 1.7901347875595093
▁on 0.033107344061136246
▁its 0.02450254000723362
▁promise 1.6840569972991943
▁of 0.02422843873500824
▁a 1.6292355060577393
▁“ 0.12219789624214172
mag 0.0016069801058620214
ic 0.013741298578679562
▁year 0.03269636258482933
” 0.015065214596688747
▁of 0.9668475389480591
▁growth 0.004831642843782902
▁for 1.6657980680465698
▁invest 0.7065091729164124
ors 0.00011218223517062142
▁in 2.6020469665527344
▁ 0.0036111031658947468
1 0.0046915621496737
9 7.939653733046725e-05
9 0.0002523383009247482
8 0.0009435693500563502
. 0.16234038770198822
